Ibex (IBEX) Q3 2026 Earnings Call Transcript

IBEX reported record Q3 revenue of $164.4 million, up 16.8% year over year, with adjusted EPS rising 11% to $0.91 and adjusted EBITDA increasing to $22 million. Management raised full-year guidance for revenue to $638 million-$642 million and adjusted EBITDA to $82 million-$84 million, while highlighting 53.7% growth in HealthTech and the launch of a strategic AI partnership with Sierra. The quarter also featured strong cash generation, $4.5 million in buybacks, and management commentary that the AI initiative should be accretive despite some cannibalization risk.

Analysis

IBEX is no longer just a labor-arbitrage BPO; the key shift is that its growth is increasingly coming from higher-margin, more defensible workloads while legacy telecom becomes a smaller drag. That mix change matters more than the headline beat because it suggests the company is compounding into a better-quality earnings stream, which should support a multiple re-rate if investors believe the new mix is durable rather than cyclical. The near-term market miss is likely to underappreciate how much of the margin expansion is driven by structural client migration and geographic mix, not just cost control.

The Sierra partnership is the real second-order catalyst. If IBEX can bundle AI-led containment with human escalation and bill under its own contract, it effectively moves up the stack from outsourced labor to workflow ownership, which can create a very sticky revenue model and higher gross margin economics. The deeper implication is competitive: smaller BPOs without AI distribution or implementation credibility may see bid displacement accelerate over the next 2-4 quarters, while enterprise buyers may increasingly prefer vendors that can show measurable containment and rapid deployment.

The risk is that management is implicitly acknowledging a transition period where AI cannibalizes legacy volumes before monetization fully offsets it. That makes the next two quarters crucial: if the AI pipeline converts into paid deployments fast enough, the market will reward the story; if not, investors may focus on the capex step-up, the impairment charge, and any margin volatility tied to capacity rebalancing. The consensus likely misses that the bigger risk is not AI adoption per se, but execution speed in packaging, pricing, and scaling it before human-volume erosion outpaces the new revenue layer.

Key Decisions for Investors

• Go long IBEX on pullbacks over the next 1-2 weeks, with a 3-6 month view: the setup favors a re-rating if AI-led bookings convert into revenue faster than the market expects. Risk/reward is attractive if the stock remains valued like a cyclical BPO rather than a hybrid software-enabled services name.
• For a higher-conviction structure, buy IBEX call spreads 3-6 months out and finance part of the premium by selling upside against prior resistance; the thesis is multiple expansion plus guide-through upside, but the capex/impairment noise can suppress near-term sentiment.
• Pair trade: long IBEX / short a basket of lower-quality outsourced service names with heavier telecom or commoditized exposure. The relative trade is about mix quality and AI adaptability, not just absolute growth.
• Avoid shorting IBEX purely on AI cannibalization in the next 30-60 days; the company is already monetizing that transition and could get credit for taking share faster than volumes roll off. The better short is any adjacent BPO that lacks proprietary workflow integration or a credible AI partnership.
• Use the next earnings cycle as a catalyst checkpoint: if AI bookings and margin commentary stay ahead of capex, add aggressively; if revenue guidance is maintained but EBITDA leverage stalls, reduce exposure because the market will likely de-rate the story back toward a traditional services multiple.